Press Releases

Company News
View Summary Apr 3, 2014
NeoGenomics Schedules its Q1 2014 Earnings Release for April 23, 2014
PDF 31.0 KB Add to Briefcase
View Summary Mar 18, 2014
NeoGenomics Announces Next Generation Sequencing Tests for Solid Tumor Cancers and Myelodysplastic Syndrome
PDF 49.1 KB Add to Briefcase
View Summary Feb 19, 2014
NeoGenomics Reports Record Revenue of $18.3 Million, Adjusted EBITDA of $2.7 Million and Net Income of $0.02 per Share for the Fourth Quarter 2013
PDF 33.2 KB Add to Briefcase
View Summary Jan 30, 2014
NeoGenomics Launches 22 New Cancer Genomic Tests Designed for Actionable Profiling of Various Hematologic and Solid Cancers
PDF 56.1 KB Add to Briefcase
View Summary Jan 17, 2014
NeoGenomics Schedules its Q4 2013 and Full Year 2013 Earnings Release for February 19, 2014
PDF 14.9 KB Add to Briefcase
View Summary Jan 7, 2014
NeoGenomics is the First Laboratory to Offer Calreticulin (CALR) Mutation Testing for the Diagnosis and Classification of Myeloproliferative Neoplasms
PDF 58.2 KB Add to Briefcase
View Summary Nov 18, 2013
Covance Central Laboratories and NeoGenomics Enter into Exclusive Alliance to Provide Comprehensive Anatomic Pathology, Histology and Specialty Laboratory Testing Services for Clinical Trials
PDF 13.9 KB Add to Briefcase
View Summary Oct 23, 2013
NeoGenomics Reports Record Revenue of $16.9 Million, Adjusted EBITDA of $2.2 Million and Net Income of $900K for the Third Quarter 2013
PDF 199.8 KB Add to Briefcase
View Summary Oct 7, 2013
NeoGenomics Schedules its Q3 2013 Earnings Release for October 23, 2013
PDF 31.1 KB Add to Briefcase
View Summary Sep 26, 2013
NeoGenomics Revises Upward its Quarter 3 2013 Guidance
PDF 12.7 KB Add to Briefcase
View Summary Jul 31, 2013
NeoGenomics Reports Revenue of $15.6 Million, Adjusted EBITDA of $1.8 Million and Earnings per share of $0.01 for the Second Quarter 2013
PDF 30.7 KB Add to Briefcase
View Summary Jul 25, 2013
NeoGenomics Introduces Comprehensive Myelodysplastic Syndrome (MDS) Molecular Testing
PDF 57.3 KB Add to Briefcase
View Summary Jul 15, 2013
NeoGenomics Schedules its Q2 2013 Earnings Release for July 31, 2013
PDF 13.3 KB Add to Briefcase
  Apr 25, 2013
NeoGenomics Reports Record Quarterly Revenue of $15.7 Million, Adjusted EBITDA of $1.8 Million and 46.3% Gross Margin for the First Quarter
PDF 79.7 KB Add to Briefcase
  Apr 17, 2013
NeoGenomics Schedules its Q1 2013 Earnings Release for April 25, 2013
PDF 31.1 KB Add to Briefcase
  Feb 28, 2013
NeoGenomics Announces Pricing of $9.5 Million Public Offering
PDF 43.4 KB Add to Briefcase
  Feb 14, 2013
NeoGenomics Reports 181% Increase in Adjusted EBITDA on 38% Revenue Growth and Achieves Profitability in 2012
PDF 105.9 KB Add to Briefcase
  Feb 5, 2013
NeoGenomics Schedules its Q4 and Full Year 2012 Earnings Release for February 14, 2013
PDF 31.1 KB Add to Briefcase
  Dec 17, 2012
NeoGenomics Validates and Launches NeoSITE™ Barrett's Esophagus FISH Test for Surveillance and Diagnosis of High Grade Dysplasia/Esophageal Cancer
PDF 57.4 KB Add to Briefcase
  Dec 6, 2012
NeoGenomics Announces NASDAQ Capital Market Listing
PDF 53.4 KB Add to Briefcase
Showing 1-20 of 47 Page: 1 2 3  Next 20
Add to Briefcase = add release to Briefcase